Telesis Bio rises as revenue more than triples

Telesis Bio

22/03/2023 11:17

** Shares of Telesis Bio  TBIO.O  up 14.03% at $2.52 in
premarket trading
    ** Posts Q4 revenue of $9.5 million, a 208% increase from a
year earlier
    ** Says rev growth was primarily due to product launches and
a milestone payment of $2.5 million from Pfizer
    ** Posts smaller loss of $8.1 million vs loss of $12.5
million 
    ** TBIO has gained 84.2% this year, through last close 

 (Reporting by Ashwini Raj in Bengaluru)
 ((Ashwini.Raj@thomsonreuters.com))